Some host factors, including inherited genetic factors, infections, autoimmune diseases, and environmental or medication exposure have been found to be associated with the development of lymphoid malignancies [ 4].
As most studies that use pharmacy databases to assess medication exposure have limited information on potential confounding factors (Wang et al, 2001; Sharpe et al, 2002; Gonzalez-Perez and Garcia Rodriguez, 2005; Haque et al, 2005), another important strength of the current study is the availability of breast cancer risk factor data.
Every GLP-1 based GLP-1 basedh sufficientherapyt exposure has generated a signal for pancreatitis, and no other diabetes medication has done so.
Exposure has become an inevitability.
Average lead exposure has also dropped.
Chi-square and independent t-tests were used to assess differences in age, sex, comorbidities, and medication exposure between patients who had had a repeat procedure and those who had not.
This requires further work, especially as a more accurate medication exposure measure would need to take into account whether drugs that have been prescribed are actually taken by patients, which could vary significantly depending on the type of medication.
The use of administrative pharmacy claims data in this study may provide more accurate information on medication exposure than self-reported medication use, although good agreement has been found between such sources [ 22].
Another limitation of this study was that consumption of the medication was not directly measured but was assumed on the basis of submitted claims; however, this approach has been shown to accurately derive medication exposure from pharmacy claims [29].
Our study had a number of strengths, including a large sample size and assessment of day-to-day medication exposure.
